{"name":"Daniel Coury","slug":"daniel-coury","ticker":"","exchange":"","domain":"","description":"Daniel Coury is a pharmaceutical company with a focus on developing and commercializing innovative treatments. The company has one marketed drug, which is a randomized Alpha 2 agonist class of medication or alternate class of stimulant. Limited financial and operational data is available.","hq":"","founded":0,"employees":"N/A","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMiigFBVV95cUxNZVFsWEdHeDNhR2JmX2tNVm44dmZYMGJ5U3p6Y2s5a0VYMGpMWjRsWG5uYjRTQkNaZ2VKQ1ZSZGY1UWdKYUQwcnE4VjBESG5kdTZrTXVIOVF6VnlHUExXR0g5TnE3TG9RR3RjTjQyVnNzVy1HSVpVRG1VZGJZMlJlSWVGMDJJdjFLR0E?oc=5","date":"2024-11-14","type":"pipeline","source":"Legacy","summary":"Daniel Jacob Obituary (1930 - 2024) - Tucson, AZ - Arizona Daily Star - Legacy","headline":"Daniel Jacob Obituary (1930 - 2024) - Tucson, AZ - Arizona Daily Star","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":2,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}